BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8870813)

  • 21. Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, non-diabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects.
    Amoah AG; Owusu SK; Ayittey OM; Schuster DP; Osei K
    Ethn Dis; 2001; 11(2):201-10. PubMed ID: 11455994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients.
    Knöbl P; Schernthaner G; Schnack C; Pietschmann P; Proidl S; Prager R; Vukovich T
    Thromb Haemost; 1994 Jun; 71(6):692-7. PubMed ID: 7974333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
    Catena C; Zingaro L; Casaccio D; Sechi LA
    Am J Med; 2000 Nov; 109(7):556-61. PubMed ID: 11063957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors.
    Montebugnoli L; Servidio D; Miaton RA; Prati C; Tricoci P; Melloni C
    J Clin Periodontol; 2004 Jan; 31(1):25-9. PubMed ID: 15058371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procoagulant activity in children and adolescents on intensive insulin therapy.
    Bratseth V; Margeirsdottir HD; Heier M; Solheim S; Arnesen H; Dahl-Jørgensen K; Seljeflot I
    Pediatr Diabetes; 2020 May; 21(3):496-504. PubMed ID: 31943582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of leptin, tumor necrosis factor-alpha, neuropeptide Y levels and their association with insulin resistance and insulin secretion function in normal glucose tolerant first-degree relatives of familial type 2 diabetic pedigrees].
    Ren Y; Li X; Tian H; Liang J; Zhang X; Yu H; Wang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1341-5. PubMed ID: 21374991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):704-9. PubMed ID: 11950714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
    Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
    Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.
    Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H; Philippou H; Lane DA; Morrison CE
    Br J Haematol; 1997 Jun; 97(4):785-97. PubMed ID: 9217177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
    Coban E; Sari R; Ozdogan M; Akcit F
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):35-7. PubMed ID: 15662593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
    Gram J; Munkvad S; Leebeek FW; Kluft C; Jespersen J
    Coron Artery Dis; 1993 Apr; 4(4):371-7. PubMed ID: 8261210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.
    Knowles NG; Landchild MA; Fujimoto WY; Kahn SE
    Diabetes Care; 2002 Feb; 25(2):292-7. PubMed ID: 11815498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
    Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
    Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
    Mansfield MW; Heywood DM; Grant PJ
    Circulation; 1996 Nov; 94(9):2171-6. PubMed ID: 8901668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients.
    Butler TJ; Barriocanal LA; Walker M
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):349-55. PubMed ID: 11589678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
    Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
    Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
    Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.